Summary
This prediction is currently active. The prediction for Altimmune disappoints with a performance of -23.54%. This prediction currently runs until 13.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | 12.826% | 12.826% |
| iShares Core DAX® | -0.318% | -0.464% |
| iShares Nasdaq 100 | -0.378% | 1.358% |
| iShares Nikkei 225® | -0.907% | 9.389% |
| iShares S&P 500 | 0.437% | 0.810% |
Comments by UBS_Group_AG for this prediction
In the thread Altimmune diskutieren
Altimmune, Inc. (NASDAQ: ALT) had its price target lowered by analysts at UBS Group AG from $26.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for ALT provided by MarketBeat